跳至主要内容
临床试验/NCT03436719
NCT03436719Unknown不适用

Randomized Controlled Trial of Antibiotic Prophylaxis in Rectal Cancer Surgery: Oral With Intravenous Versus Intravenous Antibiotics.

State Scientific Centre of Coloproctology, Russian Federation1 个研究点 分布在 1 个国家目标入组 280 人开始时间: 2017年11月6日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
280
试验地点
1
主要终点
Rate of Surgical Site Infection

研究概览

简要总结

This is a randomized, controlled, parallel study to determine the efficiency of oral antibiotics in reduction of surgical site infection (SSI) in rectal cancer surgery.

详细描述

Patients undergoing rectal cancer surgery in a single centre will assigned randomly to combined preoperative oral antibiotics (metronidazole and erythromycin) and perioperative intravenous antibiotics (cefmetazole) (oral+intravenous group) or to perioperative intravenous antibiotics (cefmetazole) alone (intravenous group). The primary endpoint is the overall rate of SSI.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Have a planned of resection of rectum
  • Have signed approved informed consent form for the study.

排除标准

  • Significant simultaneous surgical procedure (e.g., liver resection of metastasis)
  • Bacterial infection at the time of surgery or antimicrobial therapy up to 4 weeks before surgery
  • Preoperative severe impairment in renal function (creatinine clearance (MDRD) < 30 ml/min)
  • Allergy on the study drugs .

研究组 & 干预措施

Oral with Intravenous

Experimental

Oral metronidazole and erythromycine administration on the day before surgery with intravenous cefoperazone before surgery (30-90 min) and additional doses every third hour during surgery

干预措施: Oral antibiotic (Drug)

Oral with Intravenous

Experimental

Oral metronidazole and erythromycine administration on the day before surgery with intravenous cefoperazone before surgery (30-90 min) and additional doses every third hour during surgery

干预措施: Intravenous antibiotic (Drug)

Oral with Intravenous

Experimental

Oral metronidazole and erythromycine administration on the day before surgery with intravenous cefoperazone before surgery (30-90 min) and additional doses every third hour during surgery

干预措施: Mechanical Bowel Preparation (Drug)

Intravenous

Active Comparator

Intravenous dose cefoperazone before surgery (30-90 min) and additional doses every third hour during surgery

干预措施: Intravenous antibiotic (Drug)

Intravenous

Active Comparator

Intravenous dose cefoperazone before surgery (30-90 min) and additional doses every third hour during surgery

干预措施: Mechanical Bowel Preparation (Drug)

结局指标

主要结局

Rate of Surgical Site Infection

时间窗: 0 to 30 days

次要结局

未报告次要终点

研究者

发起方
State Scientific Centre of Coloproctology, Russian Federation
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Rybakov Evgeny, MD

Dr. Med. Sc. State Scientific Centre of Coloproctology, Head of Surgical department of oncoproctology, Moscow, Russian Federation

State Scientific Centre of Coloproctology, Russian Federation

研究点 (1)

Loading locations...

相似试验